On the Record · Ortho Clinical Diagnostics Holdings
Ortho Clinical Diagnostics Holdings competitors, on the record
The companies Ortho Clinical Diagnostics Holdings names as competitors in its annual reports, 2021 to 2022, and the companies that name Ortho Clinical Diagnostics Holdings, each with the sentence and the filing.
Who Ortho Clinical Diagnostics Holdings names
| Company | Named in |
|---|---|
| Abbott Laboratories | 2022 |
| Bio-Rad | 2022 |
| Danaher Corporation | 2022 |
| Diasorin | 2022 |
| Immucor | 2022 |
| Roche | 2022 |
| Siemens Healthineers | 2022 |
In its own words
Abbott Laboratories, Danaher Corporation, Roche, Siemens Healthineers
Word for word“In the Clinical Laboratories market, our principal competitors include: Abbott Laboratories, Danaher Corporation, Roche, and Siemens Healthineers.” 10-K for 2022
Bio-Rad, Diasorin, Immucor
Word for word“In the Transfusion Medicine market, our principal competitors include: Abbott Laboratories, Diasorin, Roche in Donor Screening, and Bio-Rad and Immucor in Immunohematology.” 10-K for 2022
Who names Ortho Clinical Diagnostics Holdings
Companies whose own annual reports name Ortho Clinical Diagnostics Holdings as a competitor.
Word for word“Such systems are provided by Abbott, Danaher, Ortho-Clinical Diagnostics, Roche, Siemens and other large diagnostic companies.” 10-K for 2016
Read from Ortho Clinical Diagnostics Holdings’s annual reports (10-K for 2022, 10-K for 2021) and the financial data it files with the SEC, as of 2022-03-08. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.